Pathology and Laboratory Medicine

1-2 of 2

• 

  RestartResume

  Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care

  RestartResume

  Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care

  CME/CE

  Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care

  Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD

  0.25 credits

  • 

    

    Joseph Kim, MD, MPH, MBA, FACHE

  • 

    

    Samir Dalia, MD

  • 

    

    Christopher Jurief

  0.25 credits

• 

  RestartResume

  Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC

  RestartResume

  Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC

  CME/CE

  Expert Answers to Common Questions About MET Exon 14–Skipping Mutations in NSCLC

  Mark Socinski, MD; Patrick Forde, M.B.B.Ch.

  0.25 credits

  • 

    

    Mark Socinski, MD

  • 

    

    Patrick Forde, M.B.B.Ch.

  • 

    

    Karen Reckamp, MS, MD

  0.25 credits